Untargeted metabolomics provides a broad view of small-molecule changes that sit close to phenotype, helping researchers explore the biochemical activity underlying complex biological systems. Using liquid chromatography–mass spectrometry (LC-MS), this approach supports discovery-led analysis across suitable biological sample types, conditions and experimental groups.
Novogene Europe supports untargeted metabolomics projects through its Cambridge Omics Centre, using high-resolution LC-MS analysis, metabolite annotation and bioinformatics workflows. The service helps researchers investigate differential metabolites, pathway changes, disease mechanisms, microbiome interactions and treatment response, with potential integration alongside other omics data.







